FDA approves reduced-dose pediatric asthma inhaler


The Food and Drug Administration approved Schering-Plough's Asmanex Twisthaler (mometasone furoate inhalation powder) in a 110-mcg formulation, for preventative asthma therapy for children 4 to 11 years of age....

Related Videos
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
Meghan Harrison, DO & Brittany Perry, DO
Steven Selbst, MD
© 2023 MJH Life Sciences

All rights reserved.